Vijaya Diagnostic Centre Limited
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine, radiology, laboratory, health check-ups and medical services. The company provides its services across 13 cities through its 81 diagnostic centers and 11 reference laboratories.
What Vijaya files
- Others81
- Investor Meet39
- Important16
- Board Meeting13
- Updates11
- PPTs7
Vijaya Diagnostic Centre had a strong Q1 FY27! 🚀 **Business Performance:** Revenue hit 231 Cr, up 22.8% YoY. Profit after Tax (PAT) jumped 37.6% YoY to 53.1 Cr, with an impressive 23.0% PAT margin. EBITDA grew 34.0% YoY to 98.5 Cr (42.7% margin). Hyderabad remains a key contributor (67%), and...
**Business Performance:** Vijaya Diagnostic crushed Q4 & FY26 results! Q4 revenue soared 26.6% YoY to **₹219.4 Cr**, with PAT jumping 37.5% to **₹47.9 Cr**. Full-year FY26 revenue hit **₹814.2 Cr** (up 19.5% YoY) and PAT reached **₹173.0 Cr** (up 20.3% YoY). This marks FY26 as a landmark year, outperforming their...
Vijaya Diagnostic Centre delivered strong Q3 FY26 results, with revenue jumping 21.4% year-on-year to ₹205.2 Cr. Profit After Tax (PAT) grew 22.3% to ₹43.2 Cr, while Basic EPS increased 22.2% to ₹4.2. The company saw robust operational growth, with test volumes up 14.7% and footfalls rising 11.8%. Hyderabad and the...
Vijaya Diagnostic Centre reported strong financial results for the quarter and half-year ended September 30, 2025. 1. **Business Performance:** For Q2 FY26, revenue from operations grew 10.2% year-on-year to INR 201.6 Cr, with profit after tax (PAT) at INR 43.3 Cr. Half-year (H1 FY26) revenue rose 14.9% to INR 389.6...
Here's a summary tailored to your preferences: **Financial Highlights:** Q1 FY26 revenue grew 20.4% YoY to **₹188.1 Cr**. EBITDA stood at **₹73.5 Cr** (39.1% margin), and PAT **₹38.3 Cr** (20.4% margin). The Hyderabad market saw double-digit growth. Operational performance was strong, with **11 lakh** footfalls, **39.4 lakh** tests, and 93%...